3D Surgical Planning: What the Evidence Says

How claims are graded here

Every claim on this site sits in one of four groups, and the group matters more than the wording. Established means the claim follows from evidence that is consistent across studies and is reflected in how the software, the guides or the implants are regulated and labelled — that a virtual plan fixes a bone position reproducibly, and that a printed guide carries that plan to the operating table, belong here. Limited means there is real evidence but it is narrow: a single centre, a small series, a short follow-up, or an outcome measured in a way that only partly answers the question. Emerging means the mechanism is plausible and early work points one way, but the study that would settle it has not been done. Not supported means the claim is stated confidently and the evidence does not carry it. The reason for grading rather than simply reporting is that these four groups are routinely blended into one voice. A measured bone position and a rendered face are described in the same confident register, and only one of them is something a study can establish. Where the evidence is thin, this review says so. Where a study measures a proxy rather than the thing a patient cares about, it says that too, because a plan that reproduces a bone position is not the same as a face that looks the way someone hoped.

Three regulatory classes, not one product

The software, the printed guide and the patient-facing simulation are regulated differently, and treating them as one product is where most confusion starts. Planning software is a regulated medical device in the markets that regulate it: it is cleared or approved for defined tasks such as segmentation, measurement and the generation of a surgical plan, and the clearance names those tasks rather than the outcome of an operation. A printed cutting or positioning guide is a separate device, cleared or approved on its own, usually for a named procedure and often for a specific anatomical site. A simulation rendered for a patient to look at is generally neither, because a picture that illustrates a conversation is not making a claim about a patient’s body. The distinction has a practical consequence. A device clearance is evidence that a manufacturer has demonstrated it can do a defined technical task to a regulator’s standard, and it is not evidence that an operation produces a better result. Where a clinic presents a cleared planning system and a rendered simulation as though one approval covered both, the approval is being borrowed. Approval also differs by jurisdiction, so a system available in one market may have no equivalent clearance in another, and the state of regulation changes more often than the underlying evidence does.

What the risks and limits actually are

The first risk is not technical. It is treating a persuasive image as a finding, and then making a decision on the strength of it. A rendered simulation is shown in a way designed to be understood quickly, and understanding quickly is not the same as understanding correctly. The second risk is that planning error propagates rather than cancels. A segmentation boundary traced slightly wrong, a scan taken in an unhelpful position or an artefact in the imaging all feed straight into the model, and everything computed downstream inherits the error. A plan built on a poor scan is not an approximate plan; it is a precise plan of the wrong shape. A third risk is that a guide can be seated incorrectly on the day, which is a failure of the transfer rather than of the plan, and it is why a guide is a device in its own right with its own clearances and its own failure modes. There are also limits on what planning addresses at all. A plan describes position, and an operation turns on soft tissue, healing, blood supply and how a person ages afterwards. The evidence base has limits of its own: the studies are largely single-centre series with modest numbers and short follow-up, they measure bone position rather than how a result looks or how long it lasts, and they are hard to compare with one another because the planning systems and the outcome measures differ between them.

What else is used, and when simpler planning is enough

Doing nothing is an option and it is often the right first one, because the question of whether an operation is worth having is separate from the question of how it would be planned. Where the evidence is being weighed rather than a decision made, taking time costs nothing. Where planning is genuinely wanted, the alternatives to a full three-dimensional workflow are not primitive. Photography, plain imaging and a careful examination answer some questions on their own, and a surgeon who is experienced in a procedure may reach the same plan by a route that does not involve a model. Physical models and tracings have been used for a long time and remain useful for simple movements, and planning during the operation, with the tissue in front of the surgeon, is still how a great deal of good surgery is done. Full three-dimensional planning tends to earn its cost and its complexity where the anatomy is unusual, where a movement has to be precise in more than one plane, where a patient-specific implant is being made, or where the plan needs to be shown to someone else before the day. Where a single, straightforward movement is planned and the approach would not change either way, the extra layer may add confidence without adding information — and confidence is worth less than information. The choice is a clinical one and this review does not make it for anyone.

How this review is kept current

This subject moves on two clocks at once, and the faster one is not the evidence. The evidence accumulates slowly, because a case series takes years to mature and the outcome measures in this field change more slowly still. The technology moves quickly: software is revised, new guide designs are cleared, and a system that was current when a study was published may no longer be the system a clinic uses. Regulation moves on its own schedule, and a change in what a clearance covers is a checkable fact that a reader is entitled to have current. This review is therefore dated and revisited on a short cycle, and the review covers three things. The first is whether any claim has moved between the four grading groups, in either direction, because a claim can become supported as well as cease to be. The second is regulatory status, since a new clearance or a revised indication is a fact rather than an opinion. The third is whether the evidence base has changed in kind: another single-centre series is a different event from a design that can compare planning against no planning, and only the second can settle the question of whether a complication rate falls. Where this review is wrong, the correction is made to the page rather than noted elsewhere, and the date of the most recent review is shown on every page. Where a question is genuinely unresolved, this review says that it is unresolved rather than resolving it by tone.

Related guides